Raman Spectroscopy Moves to the Front Line of Pandemic Preparedness
Comprehensive review highlights label-free viral detection – and the hurdles to real-world deployment
Clinical Scorecard: Raman Spectroscopy Moves to the Front Line of Pandemic Preparedness
At a Glance
Category Detail
Condition Pandemic-prone viral infections
Key Mechanisms Molecular fingerprinting of biological samples using Raman spectroscopy and its enhanced variants.
Target Population Individuals at risk of viral infections, including those with influenza, SARS-CoV-2, Ebola, and dengue.
Care Setting Clinical diagnostics and virology research.
Key Highlights
Raman spectroscopy offers rapid, label-free insight into viruses and host responses. Enhanced techniques like SERS, TERS, and CARS improve sensitivity and resolution. Demonstrated rapid detection of influenza and high accuracy in SARS-CoV-2 identification. Research focus is skewed towards accessible viruses, neglecting high-risk pathogens. Technical barriers include weak signal intensity and fluorescence interference.
Guideline-Based Recommendations
Diagnosis
Utilize Raman spectroscopy for rapid detection of viral infections.
Management
Integrate enhanced Raman techniques for improved diagnostic accuracy.
Monitoring & Follow-up
Employ Raman-based methods for real-time monitoring of virus-host interactions.
Risks
Address technical limitations such as weak signal intensity and regulatory hurdles.
Patient & Prescribing Data
Patients suspected of viral infections, particularly during outbreaks.
Raman spectroscopy can facilitate early diagnosis and treatment decisions.
Clinical Best Practices
Standardize Raman spectroscopy protocols to enhance reproducibility. Develop AI-driven analysis tools to streamline data interpretation. Expand research on underexplored high-risk pathogens.
References